Compendium of Cancer Genome Aberrations

Changes

HAEM5:NK-large granular lymphocytic leukaemia (view source)

Revision as of 13:56, 10 February 2025

1,111 bytes added ,  10 February
no edit summary
Line 116: Line 116:  
|EBV
 
|EBV
 
|}
 
|}
−
==Chromosomal Rearrangements (Gene Fusions)==
+
==WHO Essential and Desirable Genetic Diagnostic Criteria==
 +
<span style="color:#0070C0">(''Instructions: The table will have the diagnostic criteria from the WHO book <u>autocompleted</u>; remove any <u>non</u>-genetics related criteria. If applicable, add text about other classification'' ''systems that define this entity and specify how the genetics-related criteria differ.'')</span>
 +
{| class="wikitable"
 +
|+
 +
|WHO Essential Criteria (Genetics)*
 +
|
 +
|-
 +
|WHO Desirable Criteria (Genetics)*
 +
|
 +
|-
 +
|Other Classification
 +
|
 +
|}
 +
<nowiki>*</nowiki>Note: These are only the genetic/genomic criteria. Additional diagnostic criteria can be found in the [https://tumourclassification.iarc.who.int/home <u>WHO Classification of Tumours</u>].
 +
==Related Terminology==
 +
<span style="color:#0070C0">(''Instructions: The table will have the related terminology from the WHO <u>autocompleted</u>.)''</span>
 +
{| class="wikitable"
 +
|+
 +
|Acceptable
 +
|
 +
|-
 +
|Not Recommended
 +
|
 +
|}
 +
 
 +
==Gene Rearrangements==
 
None
 
None
   −
==Individual Region Genomic Gain / Loss / LOH==
+
==Individual Region Genomic Gain/Loss/LOH==
    
None
 
None
−
==Characteristic Chromosomal Patterns==
+
==Characteristic Chromosomal or Other Global Mutational Patterns==
    
None
 
None
−
==Gene Mutations (SNV / INDEL)==
+
==Gene Mutations (SNV/INDEL)==
    
{| class="wikitable sortable"
 
{| class="wikitable sortable"
Line 239: Line 264:     
==Notes==
 
==Notes==
−
<nowiki>*</nowiki>Primary authors will typically be those that initially create and complete the content of a page.  If a subsequent user modifies the content and feels the effort put forth is of high enough significance to warrant listing in the authorship section, please contact the CCGA coordinators (contact information provided on the homepage).  Additional global feedback or concerns are also welcome.
+
<nowiki>*</nowiki>Primary authors will typically be those that initially create and complete the content of a page.  If a subsequent user modifies the content and feels the effort put forth is of high enough significance to warrant listing in the authorship section, please contact the [[Leadership|''<u>Associate Editor</u>'']] or other CCGA representative.  When pages have a major update, the new author will be acknowledged at the beginning of the page, and those who contributed previously will be acknowledged below as a prior author.
 +
 
 +
Prior Author(s): 
 +
 
 +
       
 
<nowiki>*</nowiki>''Citation of this Page'': “NK-large granular lymphocytic leukaemia”. Compendium of Cancer Genome Aberrations (CCGA), Cancer Genomics Consortium (CGC), updated {{REVISIONMONTH}}/{{REVISIONDAY}}/{{REVISIONYEAR}}, <nowiki>https://ccga.io/index.php/HAEM5:NK-large_granular_lymphocytic_leukaemia</nowiki>.
 
<nowiki>*</nowiki>''Citation of this Page'': “NK-large granular lymphocytic leukaemia”. Compendium of Cancer Genome Aberrations (CCGA), Cancer Genomics Consortium (CGC), updated {{REVISIONMONTH}}/{{REVISIONDAY}}/{{REVISIONYEAR}}, <nowiki>https://ccga.io/index.php/HAEM5:NK-large_granular_lymphocytic_leukaemia</nowiki>.
 
[[Category:HAEM5]]
 
[[Category:HAEM5]]
 
[[Category:DISEASE]]
 
[[Category:DISEASE]]
 
[[Category:Diseases N]]
 
[[Category:Diseases N]]
Retrieved from "https://ccga.io/index.php/Special:MobileDiff/16153"